A team of reporters and camera crews packed into the headquarters of the Clinton Foundation on West 125th Street this afternoon to hear the details of former President Bill Clinton’s plan to tinker with the market for malaria drugs “in a way that has positive implications for the pharmaceutical companies,” he said.

addthis_url [...]

[Read more →]

In today’s Wall Street Journal, Mark Herrmann, an attorney with Jones Day, co-proprietor of the Drug and Device Law blog, as well as an occasional contributor to Pharm Exec, has a lively review of Alison Bass’ Side Effects, a new book that tells the story of the campaign against Paxil.
His bottom line is a [...]

[Read more →]

Looks like everyone is fair game on the Comedy Central show South Park–even Big Pharma. In one of the show’s funniest and most irreverent episodes to date, Eric Cartman (the potty-mouthed chubby kid with the poof-ball hat) becomes infected with HIV during a routine tonsillectomy. And it turns out nobody cares.
Eric goes on an adventure [...]

[Read more →]

Less than 24 hours after skewering CEO Jeffrey Kindler (right) in the press following Pfizer’s dismal Analyst Day, Wall Street’s large-cap analysts have done a stunning turnaround. In a rare show of remorse at their pitiless pile-on, these freshly contrite gurus of the pharma sector have declared the next five business days “Be Kinder to [...]

[Read more →]

Salmonella. Typhoid. Shigella. Such are the diseases of the developing world. A few years back, eliminating these diseases was a non-issue for pharma—without any Western market, it didn’t register as a priority. But if you’ve followed the intersection of pharma and philanthropy over the years the way we have we have (on AIDS, TB, and [...]

[Read more →]